CRISPR-Cas gene editing in the brain for the treatment of neurodegenerative disorders
About
Kirstan Gimse received her B.S. in Molecular Biology and Bioinformatics and Chemistry from the University of Wisconsin- Parkside after which she came to UW-Madison for graduate school. She graduated with a PhD in Cellular and Molecular Pathology in 2022 and now works as a postdoctoral researcher in the laboratories of Dr. Sushmita Roy and Dr. Krishanu Saha. Her research focuses on elucidating molecular mechanisms driving pathology in neurodegenerative disorders and on advancing gene-therapy based therapeutics for these disorders.
In her free time, Kirstan enjoys freshwater lakes and rivers, forests, reading, and her dog.
Education
- BS, Chemistry; Molecular Biology and Bioinformatics, University of Wisconsin-Parkside
- PhD, Cellular and Molecular Pathology, University of Wisconsin–Madison
Affiliations
- Somatic Cell Gene Editing Consortium
- American Society for Gene and Cell Therapy
- Society for Neuroscience
Honors
- NHGRI T32 Genomic Sciences Training Program Postdoctoral Traineeship (2022, 2023)
- ACD RNA Scope HiPlex Project Grant (2021)
- NIH T32 Cellular and Molecular Pathology Training Program Traineeship (2017)
- NSF GRFP Honorable Mention (2017)
- American Society for Neural Therapy and Repair Travel Award (2017)